S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 33 of VivoSim Labs, INC.'s SEC filings and found 7 warrant series, 2 ATM programs, 2 shelf registrations, 4 S-1 registrations and 2 completed offerings on file for VIVS. The latest dilution event on file is a registration statement on Aug 10, 2026. Analysis updated Oct 21, 2026.
Raise routes on file: active ATM + effective shelf + pending S-1 + effective S-1 · latest dilution event 85 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 10, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Proposed maximum
Shares registered
Issued 2026
Proposed maximum
Shares registered
Issued 2024
Proposed maximum
Shares registered
Issued 2024
Proposed maximum
Shares registered
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2018
Total capacity
Sold to date
Issued 2018
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2021
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z